Pharma's Sweet Relief: Drug Pricing Deal Boosts Stocks
Update: 2025-10-03
Description
Pharma's Winning Streak: Drug stocks are soaring, marking their best week in 16 years! A landmark deal between Pfizer and the US government—cutting drug prices for Medicaid in exchange for tariff protection and a massive $70 billion US investment—is fueling a market surge. With Pfizer leading the charge and other giants potentially following suit, the industry is breathing a sigh of relief after months of tariff and drug-pricing reform anxieties. The S and P Five Hundred Pharmaceuticals Index is up nearly ten percent this week, with Pfizer, Merck, and Eli Lilly shares skyrocketing, and even life science companies are feeling the positive ripple effects.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
